Eli Lilly's Phase 3 study shows tirzepatide significantly cuts type 2 diabetes risk and supports 22.9% average weight loss in adults over three years.
Following an impressive data drop this summer highlighting the potential for Eli Lilly’s tirzepatide to stave off progression ...
SA People on MSN2d
Caution issued regarding the purchase of fake OzempicSAHPRA cautions the public to not purchase and/or consume such products as their safety, efficacy, and quality have not been ...
These pose a health risk to the public. Sahpra cautions the public to not purchase and/or consume such products as their ...
Mounjaro (tirzepatide), developed by Eli Lilly and Company, is also gaining attention in South Africa. It is available in pre ...
The SA Health Products Regulatory Authority has expressed concern at the increasing presence of counterfeit products such as ...
Lou Scofield weighed her heaviest in 2023 at 17.5st and wore a size 20 clothes due to being perimenopausal and comfort eating ...
With the exploding popularity of newer weight-loss drugs, US Customs and Border Patrol has been making a lot more seizures of ...
CINCINNNATI – Since the start of summer, officers at the port of Cincinnati have seized several unapproved shipments of the ...
A SCOTS nurse is thought to be the first person to die in the UK after taking a weight loss injection recently approved by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback